Skip to main content
SpringerLink
Log in

Inflammation in Alzheimer’s Disease

  • Chapter
Molecular Mechanisms of Neurodegenerative Diseases

Part of the book series: Contemporary Clinical Neuroscience ((CCNE))

Abstract

We develop a new perspective on the interactions of amyloids and Alzheimer’s disease (AD), in which molecular and cellular changes of aging have a key role. According to our view, a subset of basic mechanisms in aging is equivalent to chronic inflammatory processes, which predispose to the deposition of amyloids in the brain and other organs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., and Tenner, A. J. (1996) Localization and cell association of Clq in Alzheimer’s disease brain. Exp. Neurol. 138, 22–32.

    Article  PubMed  CAS  Google Scholar 

  2. Aisen, P. S. and Pasinetti, G. M. (1998) Glucocorticoids in Alzheimer’s disease. The story so far. Drugs Aging 12, 1–6.

    Article  PubMed  CAS  Google Scholar 

  3. Akiyama, H., Mori, H., Saido, T., Kondo, H., Ikeda, K., and McGeer, P. L. (1999) Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer’s disease. Glia 25, 324–331.

    Article  PubMed  CAS  Google Scholar 

  4. Alzheimer, A. (1907) Uber eine einartige Erkrankung der Hindrinde. Allg. Zeitschr. Psychiatrie Psych.-Gerichtl. Med. 64, 146–148.

    Google Scholar 

  5. Translated as “A characteristic disease of the cerebral cortex,” in The Early Story of Alzheimer’s Disease (Bick K., Amaducci, L., and Pepeu, G. eds.), Livonia Press, Padova, distributed through Raven Press, New York.

    Google Scholar 

  6. Ballou, S. P. and Kushner, I. (1997) Chronic inflammation in older people: recognition, consequences, and potential intervention. Clin. Geriatr. Med. 13, 653–659.

    PubMed  CAS  Google Scholar 

  7. Barger, S. W. and Harmon A. D. (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388, 878–881.

    Article  CAS  Google Scholar 

  8. Beach, T. G. and McGeer, E. G. (1992) Senile plaques, amyloid beta-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer’s disease striate cortex. Acta Neuropathol. (Berl.) 93, 146–153.

    Article  Google Scholar 

  9. Behl, C., Davis, J.B., Lesley, R., and Schubert, D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817–827.

    Article  PubMed  CAS  Google Scholar 

  10. Benson, M. D. (1997) Aging, amyloid, and cardiomyopathy. N. Engl J. Med. 336, 502–504.

    Article  PubMed  CAS  Google Scholar 

  11. Bolanos, J. P. and Medina, J. M. (1996) Induction of nitric oxide synthase inhibits gap junction permeability in cultured rat astrocytes. J. Neurochem. 66, 2091–2099.

    Article  PubMed  CAS  Google Scholar 

  12. Borras, D., Ferrer, I., and Pumarola, M. (1999) Age-related changes in the brain of the dog. Vet. Pathol. 36, 202–211.

    Article  PubMed  CAS  Google Scholar 

  13. Cavanagh, J. B. (1999) Corpora-amylacea and the family of polyglucosan diseases. Brain Res. Brain Res. Rev. 29, 265–295.

    Article  PubMed  CAS  Google Scholar 

  14. Buxbaum, J. N. and Tagoe, C. E. (2000) The genetics of the amyloidoses. Annu. Rev. Med. 51, 543–569.

    Article  PubMed  CAS  Google Scholar 

  15. Cohen, H. J., Pieper, C. F., Harris, T., Rao, K. M., and Currie, M. S. (1997) The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J. Gerontol. A: Biol. Sci. Med. Sci. 52, M201 — M208.

    Article  CAS  Google Scholar 

  16. Cornwell, G. G., 3rd, Johnson, K. H., and Westermark, P. (1995) The age related amyloids: a growing family of unique biochemical substances. J. Clin. Pathol. 48, 984–989.

    Article  PubMed  Google Scholar 

  17. Cotman, C. W., Tenner, A. J., and Cummings, B. J. (1996) ß-Amyloid converts an acute phase injury response into chronic injury responses. Neurobiol. Aging 17, 723–731.

    Article  PubMed  CAS  Google Scholar 

  18. Cummings, B. J., Pike, C. J., Shankle, R., and Cotman, C. W. (1996) Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer’s disease. Neurobiol Aging 17, 921–933.

    Article  PubMed  CAS  Google Scholar 

  19. Cummings, B. J., Head, E., Afagh, A. J., Milgram, N. W., and Cotman, C. W. (1996) Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem. 66, 11–23.

    Article  PubMed  CAS  Google Scholar 

  20. Dentino, A. N., Pieper, C. F., Rao, M. K., Currie, M. S., Harris, T., Blazer, D. G., et al. (1999) Association of interleukin-6 and other biologic variables with depression in older people living in the community. J. Am. Geriatr. Soc. 47, 6–11.

    PubMed  CAS  Google Scholar 

  21. Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S. H. C., and Brosnan, C. (1993) Microglia and cytokines in neurological disease with special reference to AIDS and Alzheimer’s disease. Glia 7, 75–83.

    Article  PubMed  CAS  Google Scholar 

  22. Eggleton, P., Reid, K. B., and Tenner, A. J. (1998) Clq-how many functions? How many receptors? Trends Cell Biol. 8, 428–431.

    Article  PubMed  CAS  Google Scholar 

  23. Ehlerding, G., Schaeffer, J., Drommer, W., Miyata, T., Koch, K. M., and Floege, J. (1998) Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid. Nephrol. Dial. Transplant. 13, 1465–1475.

    Article  PubMed  CAS  Google Scholar 

  24. Eikelenboom, P. and Veerhuis, R. (1996) The role of complement and activated microglia in the pathogenesis of Alzheimer’ s disease. Neurobiol. Aging 17, 673–680.

    Article  PubMed  CAS  Google Scholar 

  25. Ershler, W. B. (1993) Interleukin-6: a cytokine for gerontologists. J. Am. Geriatr. Soc. 41, 176–181.

    PubMed  CAS  Google Scholar 

  26. Finch, C. E. (1993) Neuron atrophy during aging: programmed or sporadic? Trends Neurosci. 16, 104–110.

    Article  PubMed  CAS  Google Scholar 

  27. Finch, C. E. and Marchalonis, J. (1996) An evolutionary perspective on amyloid and inflammatory features of Alzheimer disease. Neurobiol. Aging 17, 809–815.

    Article  PubMed  CAS  Google Scholar 

  28. Finch, C.E. and Sapolsky, R.M. (1999). The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol. Aging 20, 427–428.

    Google Scholar 

  29. Finch, C. E. and Kirkwood, T. B. L. (1999) Chance, Development, and Aging. Oxford Univerity Press, Oxford.

    Google Scholar 

  30. Fischer, B., Schmoll, H., Riederer, P., Bauer, J., Platt, D., and Popa-Wagner, A. (1996) Complement C l q and C3 mRNA expression in the frontal cortex of Alzheimer’s patients. J. Mol. Med. 73, 465–471.

    Google Scholar 

  31. Garlind, A., Brauner, A., Hojeberg, B., Basun, H., and Schultzberg, M. (1999) Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer’s disease patients. Brain Res. 826, 112–116.

    Article  PubMed  CAS  Google Scholar 

  32. Gentleman, S. M., Greenberg, B. D., Savage, M. J., Noori, M., Newman, S. J., Roberts, G. W., et al. (1997) Abeta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. NeuroReport 8, 1519–1522.

    Article  PubMed  CAS  Google Scholar 

  33. Gitter, B. D., Cox, L. M., Rydel, R. E., and May, P. C. (1995) Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc. Natl. Acad. Sci. USA. 92, 10738–10741.

    Article  PubMed  CAS  Google Scholar 

  34. Goldsmith, S. K., Wals, P., Rozovsky, I., Morgan, T. E., and Finch, C. E. (1997) Kainic acid and decorticating lesions stimulate the synthesis of Clq protein in adult rat brain. J. Neurochem 68, 2046–2052.

    Article  PubMed  CAS  Google Scholar 

  35. Gordon, M. N., Schreier, W. A., Ou, X., Holcomb, L. A., and Morgan, D. G. (1997) Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat. J. Comp. Neurol. 388, 106–119.

    Article  PubMed  CAS  Google Scholar 

  36. Goss, J. R., Finch, C. E., and Morgan, D. G. (1990) GFAP RNA prevalence is increased in aging and in wasting mice. Exp. Neurol. 108, 266–268.

    Article  PubMed  CAS  Google Scholar 

  37. Grewal, R. P., Morgan, T. E., and Finch, C. E. (1999) C1gB and clusterin mRNA are increased in association with sporadic ALS. Neurosci. Lett. 271, 65–67.

    Article  PubMed  CAS  Google Scholar 

  38. Hansen, L. A., Armstrong, D. M., and Terry, R. D. (1987) An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex. Neurobiol. Aging 8, 1–6.

    Article  PubMed  CAS  Google Scholar 

  39. Head, E., Callahan, H., Muggenburg, B. A., Cotman, C. W., and Milgram, N. W. (1998) Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol. Aging 19, 415–425.

    Article  PubMed  CAS  Google Scholar 

  40. Higuchi, K., Kitagawa, K., Naiki, H., Hanada, K., Hosokawa, M., and Takeda, T. (1991) Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis. Biochem. J. 279, 427–433.

    PubMed  CAS  Google Scholar 

  41. Higuchi, K., Kogishi, K., Wang, J., Chen, X., Chiba, T., Matsushita, T., et al. (1998) Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab. Invest. 78, 1535–1542.

    PubMed  CAS  Google Scholar 

  42. Higuchi, K., Matsumura, A., Honma, A., Takeshita, S., Hashimoto, K., Hosokawa, M., et al. (1983) Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab. Invest. 48, 231–240.

    PubMed  CAS  Google Scholar 

  43. Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97–100.

    Article  PubMed  CAS  Google Scholar 

  44. Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G. Q., Tatsuno, G., Hu, K., et al. (1999) Plaque-independent disruption of neural circuits in Alzheimer’ s disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228–3233.

    Article  PubMed  CAS  Google Scholar 

  45. Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., et al. (1995) Age-related CNS disorder and early death in transgenic FVB/ N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203–1218.

    CAS  Google Scholar 

  46. Hu, J., LaDu, M. J., and Van Eldki, L. J. (1998) Apolipoprotein E attenuates (3-amyloid-induced astrocyte activation. J. Neurochem. 71, 1626–1634.

    Article  PubMed  CAS  Google Scholar 

  47. Hu, J., Akama, K. T., Krafft, G. A, Chromy, B. A., and Van Eldik, L. J. (1998) Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785, 195–206.

    Article  PubMed  CAS  Google Scholar 

  48. Hyman, B. T., Marzloff, K., and Arriagada, P. V. (1993) The lack of accumulation of senile plaques or amyloid burden in Alzheimer’ s disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52, 594–600.

    Article  PubMed  CAS  Google Scholar 

  49. Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., et al. (1997) Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N. Engl. J. Med. 336, 466–473.

    Article  PubMed  CAS  Google Scholar 

  50. Joachim, C. L., Mori, H., and Selkoe, D. J. (1989) Amyloid beta-protein deposition in tissues other than brain in Alzheimer’ s disease. Nature 341, 226–230.

    Article  PubMed  CAS  Google Scholar 

  51. Johnson, S. A., Lampert-Etchells, M., Rozovsky, I., Pasinetti, G., and Finch, C. E. (1992) Complement mRNA in the mammalian brain: responses to Alzheimer’s disease and experimental lesions. Neurobiol. Aging 13, 641–648.

    Article  PubMed  CAS  Google Scholar 

  52. Johnson, S. A., Pasinetti, G. M., and Finch, C. E. (1994) Expression of complement C1gB and C4 mRNAs during rat brain development. Del). Brain Res. 80, 163–174.

    Article  CAS  Google Scholar 

  53. Jucker, M., Walker, L. C., Kuo, H., Tian, M., and Ingram, D. K. (1994) Age-related fibrillar deposits in brains of C57BL/6 mice. A review of localization, staining characteristics, and strain specificity. Mol. Neurobiol. 9, 125–133.

    Article  PubMed  CAS  Google Scholar 

  54. Katzman, R. and Kawas, C.H. (1994) The epidemiology of Alzheimer disease, in Alzheimer Disease ( Terry, R. D., Katzman, R., and Bick, K. L., eds.) Raven, New York, pp. 105–122.

    Google Scholar 

  55. Kawamura, S., Takahashi, M., Ishihara, T., and Uchino, F. (1995) Incidence and distribution of isolated atrial amyloid: histologic and immunohistochemical studies of 100 aging hearts. Pathol. Int. 45, 335–342.

    Article  PubMed  CAS  Google Scholar 

  56. Kisilevsky, R. (1994) Inflammation-associated amyloidogenesis: lessons for Alzheimer’s amyloidogenesis. Mol. Neurobiol. 8, 65–66.

    Article  PubMed  CAS  Google Scholar 

  57. Kisilevsky, R. and Fraser, P. E. (1997) A beta amyloidogenesis: unique, or variation on a systemic theme? Crit. Rev. Biochem. Mol. Biol. 32, 361–404.

    Article  PubMed  CAS  Google Scholar 

  58. Krekoski, C. A., Parhad, I. M., Fung, T. S., and Clark, A. W. (1996) Aging is associated with divergent effects on Nf-L and GFAP transcription in rat brain. Neurobiol. Aging 17, 833–841.

    Article  PubMed  CAS  Google Scholar 

  59. Kristal, B. S. and Yu, B. P. (1992) An emerging hypothesis: synergistic induction of aging by free radicals and Maillard reactions. J Gerontol. 47, B 107-B 114.

    Google Scholar 

  60. Krohn, K., Rozovsky, I., Wals, P., Teter, B., Anderson, C. P., and Finch, C. E. (1999) Glial fibrillary acidic protein (GFAP) transcription responses to TGF-(31 and IL-113 are mediated by an NF-1 like site in the near-upstream promoter. J. Neurochem. 72, 1353–1361.

    Article  PubMed  CAS  Google Scholar 

  61. Kunze, W. P. (1979) Senile pulmonary amyloidosis. Pathol. Res. Pract. 164, 413–422.

    Article  PubMed  CAS  Google Scholar 

  62. Lambert, M. P., Barlow, A. K., Chromy, B., Edwards, C., Freed, R., Liosatos, M., et al. (1998) Diffusible, non-fibrillar ligands derived from Ab 1.42. Proc. Natl. Acad. Sci. USA 95, 6448–6453.

    Article  PubMed  CAS  Google Scholar 

  63. Lampert-Etchells, M., Johnson, S. A., and Finch, C. E. (1991) Alzheimer’s and normal brain contain mRNA for complement components C1gB, C3, and C4. Soc. Neurosci. Abstr. 17, 196.

    Google Scholar 

  64. Lampert-Etchells, M., Pasinetti, G. M., Finch, C. E., and Johnson, S. A. (1993) Regional localization of cells containing Clqb and C4 mRNAs in the frontal cortex during Alzheimer disease. Neurodegeneration 2, 111–121.

    Google Scholar 

  65. Lanzrein, A. S., Johnston, C. M., Perry, V. H., Jobst, K. A., King, E. M., and Smith, A. D. (1998) Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-lbeta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alphal-antichymotrypsin. Alzheimer Dis. Assoc. Disord. 12, 215–227.

    Article  PubMed  CAS  Google Scholar 

  66. Laping, N. J., Teter, B., Nichols, N. R., Rozovsky, I., and Finch, C. E. (1994) Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol. 4, 259–274.

    Article  PubMed  CAS  Google Scholar 

  67. Laping, N. J., Teter, B., Anderson, C., O’Callaghan, J. P., Johnson, S. A., and Finch, C. E. (1994) Age-related increases in glial fibrillary acidic protein are not associated with proportionate changes in transcription rates or DNA methylation in the cerebral cortex and hippocampus of male rats. J. Neurosci. Res. 39, 710–717.

    Article  PubMed  CAS  Google Scholar 

  68. Lindsay, J. D., Landfield, P. W., and Lynch, G. (1979) Early onset and topographical distribution of hypertrophied astrocytes in hippocampus of aging rats: a quantitative study. J. Gerontol. 34, 661–671.

    Article  Google Scholar 

  69. Loeffler, D.A., Brickman, C.M., Juneau, P.L., Perry, M. F„ Pomara, N., and Lewitt, P.A. (1997) Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer’s disease. Neurobiol. Aging 18, 555–557.

    Article  PubMed  CAS  Google Scholar 

  70. Marz, P., Heese, K., Hock, C., Golombowski, S., Muller-Spahn, F., Rose-John, S., et al. (1997) Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer’s disease patients. Neurosci. Lett. 239, 29–32.

    Article  PubMed  CAS  Google Scholar 

  71. McCarthy, R. E., 3rd, and Kasper, E. K. (1998) A review of the amyloidoses that infiltrate the heart. Clin. Cardiol. 21, 547–552.

    Article  PubMed  Google Scholar 

  72. Meyer, M. R., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A., Steffens, D. C., Wyse B. W., et al. (1998) APOE genotype predicts when—not whether—one is predisposed to develop Alzheimer disease. Nat. Genet. 19, 321–322.

    Article  PubMed  CAS  Google Scholar 

  73. Mor, G.,Yue, W., Santen, R. J., Gutierrez, L., Eliza, M., Berstein, L. M., et al. (1998) Macrophages, estrogen and the microenvironment of breast cancer. J. Steroid Biochem. Mol. Biol. 67, 403–411.

    Article  PubMed  CAS  Google Scholar 

  74. Morgan, T. E., Nichols, N. R., Pasinetti, G. M., and Finch, C. E. (1993) TGF-131 mRNA increases in macrophage/microglia cells of the hippocampus in response to deafferentation and kainic acid-induced in neurodegeneration. Exp. Neurol. 120, 291–301.

    Article  PubMed  CAS  Google Scholar 

  75. Morgan, T. E., Rozovsky, I., Goldsmith, S. K., Stone, D. J., Yoshida, T., and Finch, C. E. (1997) Increased transcription of the astrocyte gene GFAP during middle-age is attenuated by food restriction: implications for the role of oxidative stress. Free Radical Biol. Med. 23, 524–528.

    Article  CAS  Google Scholar 

  76. Morgan, T. E., Wals, P. A., Mohtashemi, I., Stine, W. B., Klein, W. L., Krafft, G. A., et al. (1999) A13-derived diffusible ligands (ADDLs): clusterin (apo J), Congo red binding and toxicity. Soc. Neurosci. Abstr. 25, 2130.

    Google Scholar 

  77. Morgan, T. E., Xie, Z., Goldsmith, S., Yoshida, T., Lanzrein, A.-S., Stone, D., et al. (1999) The mosaic of brain glial hyperactivity during normal aging and its attenuation by food restriction. Neuroscience 89, 687–699.

    Article  PubMed  CAS  Google Scholar 

  78. Morris, J. C., Storandt, M., McKeel, D. W., Jr, Rubin, E. H., Price, J. L., Grant, E. A., et al. (1996) Cerebral amyloid deposition and diffuse plaques in “normal” aging: evidence for presymptomatic and very mild Alzheimer’s disease. Neurology 46, 707–719.

    Article  PubMed  CAS  Google Scholar 

  79. Mrak, R. E., Groffom, S. T., and Graham D. I. (1997) Aging-associated changes in human brain. J. Neuropathol. Exp. Neurol. 56, 1269–1275.

    Article  PubMed  CAS  Google Scholar 

  80. Mucchiano, G., Cornwell, G. G., 3d., and Westermark, P. (1992) Senile aortic amyloid. Evidence for two distinct forms of localized deposits. Am. J. Pathol. 140, 871–877.

    PubMed  CAS  Google Scholar 

  81. Nichols, N. R., Day, J. R., Laping, N. J., Johnson, S. A., and Finch, C. E. (1993) GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 14, 421–429.

    Article  PubMed  CAS  Google Scholar 

  82. O’Callaghan, J. P. and Miller, D. B. (1991) The concentration of GFAP increases with age in the mouse and rat brain. Neurobiol. Aging 12, 171–174.

    Article  PubMed  Google Scholar 

  83. Oda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., et al. (1995) Clusterin (apoJ) alters the aggregation of amyloid [3-peptide (A(3 1_42) and forms slowly sedimenting A complexes that cause oxidative stress. Exp. Neurol. 136, 22–31.

    Article  PubMed  CAS  Google Scholar 

  84. Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., and Chrousos, G. P. (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128, 127–137.

    Article  PubMed  CAS  Google Scholar 

  85. Pasinetti, G. M., Johnson, S. A., Rozovsky, I., Lampert-Etchells, M., Morgan, D. G., Gordon, M. N., et al. (1992) Complement C 1 qB and C4 mRNA responses to lesioning in rat brain (1992) Exp. Neurol. 118, 117–125.

    Article  PubMed  CAS  Google Scholar 

  86. Pasinetti, G. M., Hassler, M., Stone, D., and Finch, C. E. (1999) Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions. Synapse 31, 278–284.

    Article  PubMed  CAS  Google Scholar 

  87. Pepys, M. B. (1988) Amyloidosis, in Immunological Diseases, 4th ed. ( Samter, M., ed.) Little, Brown, and Co., Boston, Vol I, pp. 631–674.

    Google Scholar 

  88. Perry, V. H., Matyszak, M., and Fearn, S. (1993) Altered antigen expression of microglia in aged rodent CNS. Glia 7, 60–67.

    Article  PubMed  CAS  Google Scholar 

  89. Pike, C. J., Cummings, B. J., Monzavi, R., and Cotman, C. W. (1994) Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer’s disease. Neuroscience 63, 517–531.

    Article  PubMed  CAS  Google Scholar 

  90. Price, D. L., Martin, L. J., Sisodia, S. S., Walker, L. C., and Cork, L. C. (1992) Alzheimer’s disease-type brain abnormalities in animal models. Prog. Clin. Biol. Res. 379, 271–287.

    PubMed  CAS  Google Scholar 

  91. Price, D. L., Tanzi, R. E., Borchelt, D. R., and Sisodia, S. S. (1998) Alzheimer’s disease: genetic studies and transgenic models. Annu. Rev. Genet. 32, 461–493.

    Article  PubMed  CAS  Google Scholar 

  92. Rabek, J. P., Scott, S., Hsieh, C. C., Reisner, P. D., and Papaconstantinou, J. (1998) Regulation of LPS-mediated induction of C/EBP delta gene expression in livers of young and aged mice. Biochim. Biophys. Acta 1398, 137–247.

    Article  PubMed  CAS  Google Scholar 

  93. Rogers, J., Webster, S., Lue, L. F., Brachova, L., Civin, W. H., Emmerling, M., et al. (1996) Inflammation and Alzheimer’s disease pathogenesis. Neurobiol. Aging 17, 681–686.

    Article  PubMed  CAS  Google Scholar 

  94. Roubenoff, R., Harris, T. B., Abad, L. W., Wilson, P. W., Dallal, G. E., and Dinarello, C. A. (1998) Monocyte cytokine production in an elderly population: effect of age and inflammation. J. Gerontol. A. Biol. Sci. Med. Sci. 53, M20 - M26.

    Article  PubMed  CAS  Google Scholar 

  95. Rozemuller, J. M., van der Valk, P., and Eikelenboom, P. (1992) Activated microglia and cerebral amyloid deposits in Alzheimer’s disease. Res. Immunol. 143, 646–649.

    Article  PubMed  CAS  Google Scholar 

  96. Rozovsky, I., Morgan, T. E., Willoughby, D. A., Dugich-Djordevich, M. N., Pasinetti, G. M., Johnson, S. A., et al. (1994) Selective expression of clusterin (SGP-2) and complement Clq and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 62, 741–758.

    Article  CAS  Google Scholar 

  97. Rozovsky, I., Finch, C. E., and Morgan, T. E. (1998) Age-related activation of microglia and astrocytes: in vitro studies show persistence of phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol. Aging 19, 97–103.

    Article  PubMed  CAS  Google Scholar 

  98. Scheinberg, M. A., Cathcart, E. S., Eastcott, J. W., Skinner, M., Benson, M., and Shirahama, T. (1976) The SJL/J mouse: a new model for spontaneous age-associated amyloidosis. I. Morphologic and immunochemical aspects. Lab. Invest. 35, 47–54.

    PubMed  CAS  Google Scholar 

  99. Schmidt, A. M., Yan, S. D., Wautier, J. L., and Stern, D. (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84, 489–497.

    Article  PubMed  CAS  Google Scholar 

  100. Schwartz, P. (1970) Amyloidosis: Cause and Manifestations of Senile Deterioration. Charles C C Thomas, Springfield, IL.

    Google Scholar 

  101. Scott, S. A. and Mandybur, T. I. (1996) Astrocytic and microglial alterations in the aged mouse brain, in Pathobiology of the Aging Mouse (Mohr, U., ed.), ISLI, Washington, DC, Vol. 2, pp. 39–52.

    Google Scholar 

  102. Sell, D. R., Lane, M. A., Johnson, W. A., Masoro, E. J., Mock, O. B., Reiser, K. M., et al. (1996) Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc. Natl. Acad. Sci. USA. 93, 485–490.

    Article  PubMed  CAS  Google Scholar 

  103. Sierra, F., Coeytaux, S., Juillerat, M., Ruffieux, C., Gauldie, J., and Guigoz, Y. (1992) Serum T-kininogen levels increase two to four months before death. J. Biol. Chem. 267, 10665–10669.

    PubMed  CAS  Google Scholar 

  104. Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., et al. (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373–379.

    PubMed  CAS  Google Scholar 

  105. Singhrao, S. K., Morgan, B. P., Neal, J. W., and Newman, G. R. (1995) A functional role for corpora amylacae based on evidence from complement studies. Neurodegeneration 4, 335–345.

    Article  PubMed  CAS  Google Scholar 

  106. Sipe, J. D. (1994) Amyloidosis. Crit. Rev. Clin. Lab. Sci. 31, 325–354.

    Article  PubMed  CAS  Google Scholar 

  107. Smyth, M. D., Cribbs, D. H., Tenner, A. J., Shankle, W. R., Dick, M., Kesslak, J. P., et al. (1994) Decreased levels of Clq in cerebrospinal fluid of living Alzheimer patients correlate with disease state. Neurobiol. Aging 15, 609–614.

    Article  PubMed  CAS  Google Scholar 

  108. Sobel, E., Louhija, J., Sulkava, R., Davanipour, Z., Kontula, K., Miettinen, H., et al. (1995) Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer’s disease among Finnish centenarians. Neurology 45, 903–907.

    CAS  Google Scholar 

  109. Price, D. L., Tanzi, R. E., Borchelt, D. R., and Sisodia, S. S. (1998) Alzheimer’s disease: genetic studies and transgenic models. Annu. Rev. Genet. 32, 461–493.

    Article  PubMed  CAS  Google Scholar 

  110. Rabek, J. P., Scott, S., Hsieh, C. C., Reisner, P. D., and Papaconstantinou, J. (1998) Regulation of LPS-mediated induction of C/EBP delta gene expression in livers of young and aged mice. Biochim. Biophys. Acta 1398, 137–247.

    Article  PubMed  CAS  Google Scholar 

  111. Takao, T., Nagano, I., Tojo, C., Takemura, T., Makino, S., Hashimoto, K., et al. (1996) Age-related reciprocal modulation of interleukin- 1 beta and interleukin-1 receptors in the mouse brain-endocrine-immune axis. Neuroimmunomodulation. 3, 205–212.

    Article  PubMed  CAS  Google Scholar 

  112. Tekirian, T. L., Cole, G. M., Russell, M. J., Yang, F., Wekstein, D. R., Patel, E., et al. (1996) Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains. Neurobiol. Aging 17, 249–257.

    Article  PubMed  CAS  Google Scholar 

  113. Terry, R. D., Gonatas, N. K., and Weiss, M. (1964) Ultrastructural studies in Alzheimer’s presenile dementia. Am. J. Pathol. 44, 269–297.

    PubMed  CAS  Google Scholar 

  114. Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., et al. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572–580.

    Article  PubMed  CAS  Google Scholar 

  115. Terry, R. D., Masliah, E., and Hansen, L. A. (1994) Structural basis of the cognitive alterations in Alzheimer disease, in Alzheimer Disease ( Terry, R. D., Katzman, R., and Bick, K. L., eds.) Raven, New York, pp. 179–196.

    Google Scholar 

  116. Thal, D. R., Sassin, I., Schultz, C., Haass, C., Braak, E., and Braak, H. (1999) Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta. J. Neuropathol. Exp. Neurol. 58, 210–216.

    Article  PubMed  CAS  Google Scholar 

  117. Thung, P. J. (1957) The relation between amyloid and ageing in comparative pathology. Gerontology 1, 234–254.

    Article  CAS  Google Scholar 

  118. Tolias, C.M., McNeil, C.J., Kazlauskaite, J., and Hillhouse, E.W. (1999) Superoxide generation from constitutive nitric oxide synthase in astrocytes in vitro regulates extracellular nitric oxide availability. Free Radical Biol. Med. 26, 99–106.

    Article  CAS  Google Scholar 

  119. Thung, P. J. (1957) The relation between amyloid and ageing in comparative pathology. Gerontology 1, 234–254.

    Article  CAS  Google Scholar 

  120. Uchida, K., Okuda, R., Yamaguchi, R., Tateyama, S., Nakayama, H., and Goto, N. (1993) Double-labeling immunohistochemical studies on canine senile plaques and cerebral amyloid angiopathy. J. Vet. Med. Sci. 55, 637–642.

    Article  PubMed  CAS  Google Scholar 

  121. Urban, B. A., Fishman, E. K., Goldman, S. M., Scott, W. W., Jr, Jones, B., Humphrey, R. L., et al. (1993) CT evaluation of amyloidosis: spectrum of disease. Radio graphics 13, 1295–1308.

    CAS  Google Scholar 

  122. Utz, J. P., Swensen, S. J., and Gertz, M. A. (1996) Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann. Intern. Med. 124, 407–413.

    Article  PubMed  CAS  Google Scholar 

  123. Muiswinkel, F. L., Raupp, S. F., de Vos, N. M., Smits, H. A., Verhoef, J., Eikelenboom, P., et al. (1999) The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages. J. Neuroimmunol. 96, 121–130.

    Article  PubMed  Google Scholar 

  124. Velazquez, P., Cribbs, D. H., Poulos, T. L., and Tenner, A. J. (1997) Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer’s disease pathogenesis. Nat. Med. 3, 77–79.

    Article  PubMed  CAS  Google Scholar 

  125. Walker, D. G. and McGeer, P. L. (1992) Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Brain Res. Mol. Brain. Res. 14, 109–116.

    Article  PubMed  CAS  Google Scholar 

  126. Walter, R., Murasko, D. M., and Sierra, F. (1998) T-kininogen is a biomarker of senescence in rats. Mech. Ageing Dey. 106, 129–144.

    Article  CAS  Google Scholar 

  127. Webster, S., Bonnell, B., and Rogers, J. (1997) Charge-based binding of complement component C l q to the Alzheimer amyloid beta-peptide. Am. J. Pathol. 150, 1531–1536.

    PubMed  CAS  Google Scholar 

  128. Wegiel, J., Wisniewski, H. M., Dziewiatkowski, J., Tarnawski, M., Dziewiatkowska, A., Morys, J., et al. (1996) Subpopulation of dogs with severe brain parenchymal beta amyloidosis distinguished with cluster analysis. Brain Res. 728, 20–26.

    Article  PubMed  CAS  Google Scholar 

  129. Wei, M., Rozovsky, I., Lopez, L. M., Morgan, T. E., and Finch, C. E. (1999) Oxidative stress and the GFAP promoter. Soc. Neurosci. Abstr. 25, 1317.

    Google Scholar 

  130. Wen, G. Y., Wisniewski, H. M., Blondal, H., Benedikz, E., Frey, H., Pirttila, T., et al. (1994) Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer’s disease (AD), Down’s syndrome and non-AD normal persons. Acta Neuropathol (Berl.) 88, 201–206.

    Article  CAS  Google Scholar 

  131. West, W. T. and Murphy, E. D. (1965) Sequence of deposition of amyloid in strain A mice and relationship to renal disease. J. Natl. Cancer Inst. 35, 167–174.

    PubMed  CAS  Google Scholar 

  132. Westermark, P., Eriksson, L., Engstrom, U., Enestrom, S., and Sletten, K. (1997) Prolactin-derived amyloid in the aging pituitary gland. Am J Pathol. 150, 67–73.

    PubMed  CAS  Google Scholar 

  133. Westermark, P., Mucchiano, G., Marthin, T., Johnson, K. H., and Sletten, K. (1995) Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am. J. Pathol. 147, 1186–1192.

    PubMed  CAS  Google Scholar 

  134. Westermark, P., Sletten, K., Naeser, P., and Natvig, J. B. (1979) Characterization of amyloid of ageing obese-hyperglycaemic mice and their lean littermates. Scand. J. Immunol. 9, 193–196.

    Article  PubMed  CAS  Google Scholar 

  135. Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., et al. (1997)Amyloidogenic role of cytokine TGF-betal in transgenic mice and in Alzheimer’s disease. Nature 389, 603–606.

    Google Scholar 

  136. Xie, Z., Wals, P. A., Walsh, J. P., Finch, C. E., and Morgan, T. E. (1998) Characterization of clusterin-induced microglial activation. Soc. Neurosci. 24, 1944.

    Google Scholar 

  137. Yamaguchi, H., Hirai, S., Morimatsu, M., Shoji, M., and Ihara, Y. (1988) A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining. Acta Neuropathol. (Berl.) 76, 541–549.

    Article  CAS  Google Scholar 

  138. Yasojima, K., Schwab, C., McGeer, E. G., and McGeer, P. L. (1999) Up-regulated production and activation of the complement system in Alzheimer’s disease brain. Am. J. Pathol. 154, 927–936.

    Article  PubMed  CAS  Google Scholar 

  139. Yasuma, T., Arai, K., and Suzuki, F. (1992) Age-related phenomena in the lumbar intervertebral discs. Lipofuscin and amyloid deposition. Spine 17, 1194–1198.

    Article  PubMed  CAS  Google Scholar 

  140. Yoshida, T., Goldsmith, S., Morgan, T. E., Stone, D., and Finch, C. E. (1996) Transcription supports age-related increases of GFAP gene expression in the male rat brain. Neurosci. Lett. 215, 107–110.

    Article  PubMed  CAS  Google Scholar 

  141. Zanjani, H., Lanzrein, A. S., McKeel, D. W., Morris, J. C., and Finch, C. E. (1999) clusterin and complement components Clq and C3 deposits increased at very early stages of Alzheimer disease (AD). Soc. Neurosci. Abstr. 25, 1102.

    Google Scholar 

  142. Zhan, S. S., Veerhuis, R., Janssen, I., Kamphorst, W., and Eikelenboom, P. (1994) Immunohistochemical distribution of the inhibitors of the terminal complement complex in Alzheimer’s disease. Neurodegeneration 3, 111–117.

    Google Scholar 

  143. Zhan, S. S., Veerhuis, R., Kamphorst, W., and Eikelenboom, P. (1995) Distribution of beta amyloid associated proteins in plaques in Alzhemer’s disease and in the non-demented elderly. Neurode generation 4, 291–297.

    Article  CAS  Google Scholar 

  144. Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., and Wanner, C. (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 55, 648–658.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Caleb E. Finch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valter Longo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aya Miyao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Todd E. Morgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Irina Rozovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yubei Soong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Min Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhong Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hadi Zanjani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Finch, C.E. et al. (2001). Inflammation in Alzheimer’s Disease. In: Molecular Mechanisms of Neurodegenerative Diseases. Contemporary Clinical Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-006-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-006-3_4

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-197-4

  • Online ISBN: 978-1-59259-006-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation